Skip to main content

Phathom Pharmaceuticals, Inc.

PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001783183

No open-market purchases or sales by Phathom Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $782.1M in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Phathom Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
173
+40 vs. Q3 2025
Shares held
62.0M
−370.1K (−0.6%) vs. Q3 2025
Total value
$1.03B
+$291.9M (+39.8%) vs. Q3 2025
New holders
50
49 more added
Sold out
10
50 more reduced

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PHAT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 173 institutions
Q1 2021: 84 institutionsQ2 2021: 79 institutionsQ3 2021: 84 institutionsQ4 2021: 83 institutionsQ1 2022: 82 institutionsQ2 2022: 94 institutionsQ3 2022: 94 institutionsQ4 2022: 87 institutionsQ1 2023: 84 institutionsQ2 2023: 103 institutionsQ3 2023: 110 institutionsQ4 2023: 117 institutionsQ1 2024: 114 institutionsQ2 2024: 114 institutionsQ3 2024: 133 institutionsQ4 2024: 144 institutionsQ1 2025: 137 institutionsQ2 2025: 117 institutionsQ3 2025: 133 institutionsQ4 2025: 173 institutionsQ1 2026: 174 institutionsQ2 2026: 161 institutions
Value heldQ4 2025: $1.03B
Q1 2021: $919.2MQ2 2021: $843.6MQ3 2021: $819.8MQ4 2021: $562.0MQ1 2022: $349.1MQ2 2022: $230.0MQ3 2022: $334.3MQ4 2022: $316.6MQ1 2023: $219.7MQ2 2023: $612.6MQ3 2023: $452.7MQ4 2023: $503.3MQ1 2024: $588.2MQ2 2024: $598.6MQ3 2024: $1.31BQ4 2024: $541.2MQ1 2025: $401.4MQ2 2025: $550.5MQ3 2025: $733.6MQ4 2025: $1.03BQ1 2026: $765.5MQ2 2026: $782.1M
Institutions holding PHAT and their total value by quarter
QuarterHoldersValue
Q2 2026161$782.1M
Q1 2026174$765.5M
Q4 2025173$1.03B
Q3 2025133$733.6M
Q2 2025117$550.5M
Q1 2025137$401.4M
Q4 2024144$541.2M
Q3 2024133$1.31B
Q2 2024114$598.6M
Q1 2024114$588.2M
Q4 2023117$503.3M
Q3 2023110$452.7M
Q2 2023103$612.6M
Q1 202384$219.7M
Q4 202287$316.6M
Q3 202294$334.3M
Q2 202294$230.0M
Q1 202282$349.1M
Q4 202183$562.0M
Q3 202184$819.8M
Q2 202179$843.6M
Q1 202184$919.2M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Phathom Pharmaceuticals, Inc.; share changes are against Q3 2025.

Institutions holding PHAT in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
XTX Topco Ltd39,400$653.6K0.02%−15,187−27.8%Reduced
California State Teachers Retirement System40,143$666.0K0.00%+37,252+1,288.6%Added
New York State Common Retirement Fund41,756$692.7K0.00%+30,986+287.7%Added
Southeast Asset Advisors Inc.42,874$711.3K0.07%+42,874New
ADAR1 Capital Management, LLC42,900$711.7K0.05%00.0%Unchanged
Engineers Gate Manager LP44,258$734.2K0.01%+44,258New
Virtus Investment Advisers, Inc.46,937$778.7K0.21%+2,631+5.9%Added
Alliancebernstein L.P.49,390$819.4K0.00%+3,800+8.3%Added
Stratos Wealth Partners, LTD.50,300$834.5K0.01%+50,300New
Stifel Financial Corp51,661$857.1K0.00%+31,794+160.0%Added
Rhumbline Advisers52,093$864.2K0.00%−9,620−15.6%Reduced
AQR Capital Management LLC54,448$903.3K0.00%+1,819+3.5%Added
Two Sigma Investments, LP57,783$958.6K0.00%+57,783New
Dark Forest Capital Management LP62,248$1.03M0.05%+62,248New
Penn Mutual Asset Management, LLC62,802$1.04M0.62%00.0%Unchanged
Wells Fargo & Company68,016$1.13M0.00%+14,368+26.8%Added
Creative Planning80,766$1.34M0.00%+2,708+3.5%Added
Gsa Capital Partners LLP82,624$1.37M0.12%+12,366+17.6%Added
Swiss National Bank84,000$1.39M0.00%+84,000New
Barclays PLC84,859$1.41M0.00%−43,497−33.9%Reduced
VARCOV Co.86,759$1.44M0.57%+86,759New
Group One Trading, L.P.103,684$1.72M0.05%+99,436+2,340.8%Added
Nuveen, LLC108,846$1.81M0.00%−1,264−1.1%Reduced
Hennion & Walsh Asset Management, Inc.114,981$1.91M0.07%+114,981New
Campbell & CO Investment Adviser LLC115,284$1.91M0.09%+115,284New
Morgan Stanley117,781$1.95M0.00%−137,792−53.9%Reduced
Bank of New York Mellon Corp122,967$2.04M0.00%−4,415−3.5%Reduced
Wellington Management Group LLP134,546$2.23M0.00%−11,913−8.1%Reduced
Trexquant Investment LP136,824$2.27M0.02%+58,641+75.0%Added
Gilder Gagnon Howe & Co LLC145,174$2.41M0.03%+56,632+64.0%Added
Hussman Strategic Advisors, Inc.147,000$2.44M0.59%+147,000New
Caxton Associates LLP181,968$3.02M0.06%+143,398+371.8%Added
Ameriprise Financial Inc185,744$3.08M0.00%−368,846−66.5%Reduced
Woodline Partners LP187,291$3.11M0.01%00.0%Unchanged
GWM Advisors LLC200,823$3.16M0.01%−700−0.3%Reduced
Birchview Capital, LP195,000$3.24M1.89%+110,000+129.4%Added
Avidity Partners Management LP206,076$3.42M0.99%−99,924−32.7%Reduced
Balyasny Asset Management LLC207,085$3.44M0.01%−88,076−29.8%Reduced
Bank of America Corp258,996$4.30M0.00%+9,902+4.0%Added
D. E. Shaw & Co., Inc.261,068$4.33M0.00%+261,068New
Susquehanna Portfolio Strategies, LLC267,962$4.45M0.07%00.0%Unchanged
Brevan Howard Capital Management LP276,989$4.60M0.09%+218,892+376.8%Added
JPMorgan Chase & Co296,684$4.92M0.00%+159,736+116.6%Added
StepStone Group LP422,085$4.97M2.66%00.0%Unchanged
UBS Group AG304,383$5.05M0.00%−33,977−10.0%Reduced
Citadel Advisors LLC311,315$5.16M0.00%−197,405−38.8%Reduced
Simplify Asset Management Inc.321,935$5.34M0.09%00.0%Unchanged
Northern Trust Corp356,466$5.91M0.00%−1,112−0.3%Reduced
Jane Street Group, LLC384,770$6.38M0.01%+277,508+258.7%Added
Goldman Sachs Group Inc392,045$6.50M0.00%+240,013+157.9%Added
Next Century Growth Investors LLC393,774$6.53M0.45%+393,774New
Charles Schwab Investment Management Inc397,910$6.60M0.00%+32,006+8.7%Added
SummitTX Capital, L.P.517,820$8.59M0.26%+131,852+34.2%Added
Susquehanna International Group, LLP549,171$9.11M0.01%+394,894+256.0%Added
Moore Capital Management, LP600,000$9.95M0.20%00.0%Unchanged
Divisadero Street Capital Management, LP662,312$11.0M0.63%+662,312New
Catalio Capital Management, LP698,996$11.6M2.05%−429,525−38.1%Reduced
Propel Bio Management, LLC740,918$12.3M10.49%+187,991+34.0%Added
Geode Capital Management, LLC1,073,434$17.8M0.00%−15,476−1.4%Reduced
State Street Corp1,149,536$19.1M0.00%+95,945+9.1%Added
GW&K Investment Management, LLC1,306,678$21.7M0.19%+162,348+14.2%Added
Wasatch Advisors Inc1,331,669$22.1M0.13%−205,549−13.4%Reduced
Catalys Pacific, LLC1,429,014$23.7M7.63%+261,900+22.4%Added
683 Capital Management, LLC1,785,000$29.6M2.46%−35,380−1.9%Reduced
NEA Management Company, LLC1,960,169$32.5M1.66%00.0%Unchanged
Millennium Management LLC2,082,180$34.5M0.02%−2,999,271−59.0%Reduced
Ensign Peak Advisors, Inc2,352,020$39.0M0.07%−151,324−6.0%Reduced
Vanguard Group Inc3,177,211$52.7M0.00%−38,361−1.2%Reduced
Carlyle Group Inc.3,496,808$58.0M0.43%00.0%Unchanged
BlackRock, Inc.3,555,548$59.0M0.00%+153,224+4.5%Added
Invesco Ltd.3,920,446$65.0M0.01%+55,475+1.4%Added
Medicxi Ventures Management (Jersey) Ltd7,464,572$123.8M14.83%00.0%Unchanged
Frazier Life Sciences Management, L.P.12,466,489$206.8M5.55%00.0%Unchanged
AIGH Capital Management LLC0$00.00%−429,000−100.0%Sold out
Walleye Capital LLC0$00.00%−290,467−100.0%Sold out
PharVision Advisers, LLC0$00.00%−30,968−100.0%Sold out
Quadrature Capital Ltd0$00.00%−30,272−100.0%Sold out
Omers Administration Corp0$00.00%−16,500−100.0%Sold out
Kestra Private Wealth Services, LLC0$00.00%−15,500−100.0%Sold out
Quarry LP0$00.00%−7,007−100.0%Sold out
Leonteq Securities AG0$00.00%−4,800−100.0%Sold out
Bear Mountain Capital, Inc.0$00.00%−1,000−100.0%Sold out
SBI Securities Co., Ltd.0$00.00%−23−100.0%Sold out